Dorte Lisbet Nielsen

Dorte Lisbet Nielsen

Professor emeritus.

Member of:

  • Clinical Oncology


  1. 2014
  2. Published

    A systematic review of bevacizumab efficacy in breast cancer

    Kümler, I., Christiansen, O. G. & Nielsen, Dorte Lisbet, Sep 2014, In: Cancer Treatment Reviews. 40, 8, p. 960-973 14 p.

    Research output: Contribution to journalReviewResearchpeer-review

  3. Published

    A systematic review of salvage therapy to patients with metastatic colorectal cancer previously treated with fluorouracil, oxaliplatin and irinotecan +/- targeted therapy

    Nielsen, Dorte Lisbet, Palshof, J. A., Larsen, F. O., Jensen, B. V. & Pfeiffer, P., Jul 2014, In: Cancer Treatment Reviews. 40, 6, p. 701-715 15 p.

    Research output: Contribution to journalReviewResearchpeer-review

  4. Published

    PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patients

    Jørgensen, C. L. T., Nielsen, T. O., Bjerre, K. D., Liu, S., Wallden, B., Balslev, E., Nielsen, Dorte Lisbet & Ejlertsen, B., Jun 2014, In: Acta Oncologica. 53, 6, p. 776-787 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    A systematic review of dual targeting in HER2-positive breast cancer

    Kümler, I., Tuxen, M. K. & Nielsen, Dorte Lisbet, Mar 2014, In: Cancer Treatment Reviews. 40, 2, p. 259-270 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity

    Polk, A., Vistisen, K., Vaage-Nilsen, M. & Nielsen, Dorte Lisbet, 2014, In: BMC Pharmacology and Toxicology. 15, p. 1-11 11 p.

    Research output: Contribution to journalReviewResearchpeer-review

  7. Published

    Cardiotoxicity in Asymptomatic Patients Receiving Adjuvant 5-fluorouracil

    Nielsen, K., Polk, A., Nielsen, Dorte Lisbet, Vistisen, K. K. & Vaage-Nilsen, M. B., 2014, In: Journal of Clinical Toxicology. 4, 5, 2 p., 211.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer

    Tuxen, M. K., Cold, S., Tange, U. B., Balslev, E. & Nielsen, Dorte Lisbet, 2014, In: Acta Odontologica Scandinavica. 53, 10, p. 1440-1445 6 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  9. 2013
  10. Published

    Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine

    Jørgensen, C. L. T., Ejlertsen, Bent Laursen, Bjerre, K. D., Balslev, E., Nielsen, Dorte Lisbet & Nielsen, K. V., 12 Nov 2013, In: B M C Cancer. 13, p. 1-11 11 p., 541.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    A systematic review of trastuzumab and lapatinib in the treatment of women with brain metastases from HER2-positive breast cancer

    Larsen, P. B., Kümler, Iben & Nielsen, Dorte Lisbet, 2013, In: Cancer Treatment Reviews. 39, 7, p. 720-727 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine

    Polk, A., Vaage-Nilsen, M. B., Vistisen, K. & Nielsen, Dorte Lisbet, 2013, In: Cancer Treatment Reviews. 39, 8, p. 974–984 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1...4 5 6 7 8 9 Next

ID: 10804194